Ev Lin
FDA investigator
Appears on 1 document from 2024, mostly at sites in North Carolina. Most often cites control of microbiological contamination (21 CFR 211.113).
- 1
- Documents on file
- 15.0
- Observations per 483
- 2024
- First seen
- 2024
- Most recent
What they cite most
From 15 observations- 21 CFR 211.113Control of microbiological contamination2
- 21 CFR 211.194Laboratory records2
- 21 CFR 211.160General requirements1
- 21 CFR 211.165Testing and release for distribution1
- 21 CFR 211.166Stability testing1
- 21 CFR 211.170Reserve samples1
Activity by year
2024: 1
Where
North Carolina 1
Often inspects with
Is Ev Lin coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2024-11-15 | 483 Exela Pharma Sciences, LLCNov 15, 2024 · Lenoir, North Carolina | Lenoir, North Carolina | 15 |
About this profile
What does Ev Lin inspect?
Ev Lin appears on 1 document on file covering 1 site, mostly in North Carolina.
What do they cite most often?
21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.194 and 21 CFR 211.160.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Ev Lin is dated Nov 15, 2024.